Get started

Athersys, Inc.

No trades
See on Supercharts
Overview
News Ideas Financials Technicals

ATHX chart

Key stats

Market capitalization
9.473MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−3.0320USD
Net income
−72.534MUSD
Revenue
5.325MUSD
Shares float
21.893M
Beta
−0.3

About Athersys, Inc.

Sector
Health Technology
Industry
Biotechnology
CEO
Daniel A. Camardo
Website
athersys.com
Headquarters
Cleveland
Employees (FY)
24
Founded
1995
ISIN
US04744L2051

Athersys, Inc. is a biotechnology company, which focuses on the field of regenerative medicine. It engages in the discovery and development of therapies designed to extend and enhance the quality of human life. The firm offers MultiStem as its stem cell product which provides biological potency and therapeutic effects for distinct diseases and conditions in the cardiovascular, neurological, inflammatory, and immune disease areas. The company was founded by John J. Harrington and Gil van Bokkelen on October 24, 1995 and is headquartered in Cleveland, OH.

Ideas

$ATHX is gonna fall todayPupm&Dump trading strategy idea. $ATHX is rising too much today. The demand for shares of the company looks lower than the supply. This and other conditions can cause a fall in the share price today. So I opened a short position from $1,76; stop-loss — $1,87; take-profit — $1,56. Do not view th
ATHX LongGap up, trendline break Possible double bottom WR Crossed -80 OBV>OBV34 Entry 1.5 Stop 1.3 Target 3.0 Risk management is much more important than a good entry point. The max Risk of each plan should be less than 1% of an account. I am not a PRO trader. I trade option to test my trading plan wi
Long
ATHX Technical Analysis 🧙Athersys Inc is a clinical-stage biotechnology company. It is focused on developing novel and proprietary therapies in the areas where there is a significant unmet medical need, particularly in the regenerative medicine area. The firm's main product is Multistem cell therapy. Its current clinical de
Long
Athersys, Inc. - wait pullback to 2.31 and then buyAthersys, Inc. The solid gain came after the company and the University of Texas Health Science Center at Houston announced the enrollment of the first patient in a phase 2 clinical study evaluating the company's MultiStem cell therapy as a potential early treatment for traumatic injuries. The co
Long
ATHX 88%ATHX recently broke out of a descending wedge that took it from the top of the channel to the bottom...after 9 weeks of consolidation, it is now trading above all major moving averages...monday saw a break above the 200 day ma and today saw a retest...macd is in positive territory and looks to be ho
Long
ATHX breaking $2.54 might signal a true breakout.So this might be trash, but I think breaking above $2.54 may signal real positive movement. The MACD is tapping 0.10, while the Ichimoku has the lagging indicator breaking out for more than a day. Add all that together with triple the average volume today (Feb. 2nd), a couple larger than average buy
Long

See all ideas 

News Flow

Keep readingKeep reading

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Financials

Performance
Revenue to profit conversion
No revenue here
This company hasn't generated any revenue in the last financial year
Debt level and coverage
Earnings
Next:—
‪0‬

Trading & brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
TradeStation
TradeStation
Featured
Stocks, Crypto, Futures
4.4Very Good
Learn more
Interactive Brokers
Interactive Brokers
Stocks, Futures, Bonds
4.3Good
Learn more

See all brokers